Scientific publications

Twists and turns to translating 4-1BB cancer immunotherapy

Jun 12, 2019 | Magazine: Science Translational Medicine

Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, Ignacio Melero

Abstract

Previous shortcomings of CD137-targeted immunotherapy may be overcome by engineered bispecific agents (Claus et al, this issue).

CITATION  Sci Transl Med. 2019 Jun 12;11(496):eaax4738. doi: 10.1126/scitranslmed.aax4738.

see publication in pubmed

Our authors

Dr. Miguel Fernández de Sanmamed Gutiérrez Curriculum
Specialist Medical Oncology Department
Navarre headquarters
Imagen Dr. Ignacio Melero Bermejo, Inmunología
Dr. Ignacio Melero Bermejo Curriculum
Codirector Immunology and Immunotherapy Department
Navarre headquarters